# MediVentures

MediVentures is a Venture Capital based in Iserlohn, Germany.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Iserlohn, Germany
- **Region:** Europe
- **Address:** Medice Allee 1, 58638 Iserlohn, Germany
- **Founded:** 2019
- **Assets under management:** Undisclosed
- **Website:** www.medi.ventures
- **LinkedIn:** https://linkedin.com/company/mediventures

## Regulatory record

- **Reports private funds:** No

## About

MediVentures is the venture capital arm of the Puetter family office. It started in 2019 as an early-stage investor in digital health ventures and in 2024 began pivoting to investing into VC funds, with capacity for opportunistic co-investments, while continuing to support existing portfolio companies. It promotes future-proof technologies in a sustainable healthcare system.

## Sectors

- Digital Health
- AgriTech & FoodTech
- Energy Transition & Renewables
- ClimateTech
- SpaceTech

## People

- Philipp Große — Managing Director

## Questions

### Who runs investment decisions at MediVentures?

Managing Director Philipp Große leads the firm. He operates from the Puetter family office's headquarters in Iserlohn, Germany. The governance structure places final investment authority with the family office, aligning fund commitments and co-investments with the broader family capital strategy.

### Does MediVentures participate in fund commitments or only direct deals?

Since announcing its 2024 pivot, the primary strategy is fund commitments. The firm enters LP positions of up to €5 million per fund. It retains the capacity to make opportunistic direct co-investments with the funds it has already backed.

### What investment stages does MediVentures typically target?

The firm focuses on funds active at pre-seed, seed, Series A, and Series B. It also evaluates special vehicles for secondary investments and profit-driven impact funds. This stage coverage runs from company formation through early growth.

### How does MediVentures source proprietary deal flow?

The firm's sourcing model relies on relationships with established and first-time GPs across the EU, EFTA, and UK. By entering LP positions, MediVentures gains visibility into the underlying portfolio companies, creating a proprietary pipeline for direct co-investments without maintaining a standalone origination team.

## Related profiles

- [Mediterrania Capital Partners](https://altss.com/profile/mediterrania-capital-partners)
- [Medizinpark Valley](https://altss.com/profile/medizinpark-valley)

---

Last updated: 2026-08-11T15:07:26.757Z

Canonical page: https://altss.com/profile/mediventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology